Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells.

Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Abstract Text:

    haiming xuHaiming Xu,donghong juDonghong Ju,tiffany jaroisTiffany Jarois,youming xieYouming Xie,

    Clinical trials with proteasome inhibitor Bortezomib (also named Velcade or PS-341) has shown promising results for some cancers. However, other types of cancers including breast cancer do not respond well to Bortezomib. To understand the cause of the drug resistance, we compared the regulation of proteasome expression and the sensitivity to proteasome inhibitors between human breast cancer cells and nontumorigenic mammary epithelial cells. We found that, while the endogenous expression level is much higher, the potential of feedback expression in response to proteasome inhibitors is much lower in the breast cancer cells. Furthermore, the breast cancer cells are much more resistant to proteasome inhibitors compared to the nontumorigenic mammary epithelial cells. Biochemical analysis showed that the pathway of Bortezomib-induced apoptosis is apparently defective in the breast cancer cells. Together, these results provide an explanation for the inefficacy of Bortezomib in the clinical trials for breast cancer patients. The likelihood of combination therapy with Bortezomib and other anti-cancer agents for breast cancer is also discussed.

    Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Publishing Authors By Initials

    h xuH Xu,d juD Ju,t jaroisT Jarois,y xieY Xie,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Breast cancer research and treatment

    VOLUME: 107

    Page Numbers: 267-74

    Journal Abbreviation: Breast Cancer Res. Treat.

    ISSN: 0167-6806

    DAY: 13

    MONTH: 03

    YEAR: 2007

    Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8111104

    Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells.

    AFFILIATION: Barbara Ann Karmanos Cancer Institute, Department of Pathology, Wayne State University School of Medicine, 110 E Warren Ave, Detroit, MI, 48201, USA, xiey@karmanos.org.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Breast Cancer Res Treat

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News